.
.
.

Notes: Focused on the Cure for Cancer:  
Tumor Infiltrating Lymphocyte Therapy

Cell mutations, occur naturally in every healthy person, as does the bodies immune capacity to destroy abnormal cells, this makes every person a cancer survivor.  When the mutation equilibrium, or the abnormal cells grow beyond the immune systems capabilities, then we are presented with a clinical challenge.  The following academic discussions are focused on stimulation of the bodies own immune capacity to destroy an abnormal cellular challenge as a primary treatment or cure for cancer.

-----------------------------------

8 December 2010

Pathobiologics International:
Url: www.pathobiologics.org

HRI:UNArts - Millennium Medicine Project
Url: www.pathobiologics.org/mmp

Never Give Up: Cancer Journal & Resources
Url: www.unarts.org/nevergiveup


 

Dear Colleagues:

I am extending an appeal through the International Veterinary Public Health Consortium to medical/veterinary colleagues and research facilities in every UN member country that are advancing work/treatment with Tumor Infiltrating Lymphocyte Therapy.  

I would appreciate your assistance with acquiring papers and related information on:

1. Cell transfer immunotherapy
2. Lymphocyte acquisition from biopsy/tissue sample
3. Laboratory induced Lymphocyte replication
4. Mutation specific enhanced immune stimulation

During my early stages of cancer diagnosis and review of treatment options, I was shocked to learn that this treatment was not available to me or the worlds top cancer specialists directing my care.  It is my hope, that that we will be able to fast track validation, standardization and access of this cancer treatment option in the United States and abroad.

In deepest appreciation of your help and support of Anti-Cancer Research and Development.

Stephen M. Apatow
Founder, Director of Research & Development
Pathobiologics International
Humanitarian University Consortium Graduate Studies
Center for Medicine, Veterinary Medicine & Law
Phone: 203-668-0282
Email: s.m.apatow@pathobiologics.org
Internet: www.pathobiologics.org

 

-----------------------------------------

15 October 2010

Humanitarian Resource Institute
Phone: (203) 668-0282
Url: www.humanitarian.net

Never Give Up: Cancer Journal & Resources
Url: www.unarts.org/nevergiveup
Facebook: Never Give Up


 

Dear Colleagues
Cancer as a disease can be summarized as a disruption of the mutational equilibrium or the capacity of the immune system recognize abnormal cell growth (or mutations) and upon recognition, destruction of the challenge.   Cancer treatment that focuses on enhancement of the immune system, represents the most logical, safe and effective treatment approach for all neoplastic disease.  

It is my objective to engage every level of the international  biodefense, veterinary public health and the medical research community into a focus to facilitate mainstream access to related treatment approaches.  Prioritization includes:

Tumor Infiltrating Lymphocyte Therapy: A specific type of cell transfer immunotherapy, in which the lymphocytes infused back into the patient are from the patients own tumor.  These lymphocytes are actually infiltrating and trying to destroy the tumor and they are obtained when the tumor is biopsied or excised. The tumor infiltrating lymphocytes contain a large concentration of cytotoxic T lymphocytes specifically targeted against the antigens in the patients own tumor as well as numbers of natural killer lymphoctes that can destroy tumor cells .  The lymphocytes are grown in a laboratory with interleukin-2 to stimulate growth of the lymphocytes and then infused back into the patient to attack and destroy the tumor. -- Neoplastic Disease: An Introduction to Human Disease: Pathology and Pathophysiology Correlations, Leonard V. Crowley.

Please see: Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma: Journal of Translational Medicine 2007, 5:68. (Full Text). 

Related

Looking forward to your feedback,

Stephen M. Apatow
Founder, Director of Research & Development
Pathobiologics International
Humanitarian University Consortium Graduate Studies
Center for Medicine, Veterinary Medicine & Law
Phone: 203-668-0282
Email: s.m.apatow@pathobiologics.org
Internet: www.pathobiologics.org


----------------------------------------

One Health Initiative Unites Human and Veterinary Medicine:
Humanitarian Resource Institute, United Nations Arts Initiative.

 
The One Health Initiative is a movement to forge co-equal, all inclusive collaborations between physicians, veterinarians, and other scientific-health and environmentally related disciplines, including the American Medical Association, American Veterinary Medical Association, the American Society of Tropical Medicine and Hygiene, the Centers for Disease Control and Prevention (CDC), the United States Department of Agriculture (USDA), and the U.S. National Environmental Health Association (NEHA). Additionally, more than 535 prominent scientists, physicians and veterinarians worldwide have endorsed the initiative.
Url: http://www.onehealthinitiative.com

----------------------------------------


Back to Humanitarian Resource Institute

Copyright © 1994-2011 Humanitarian Resource Institute.  All rights reserved
..